Skip to main content

Pure-Play Psychedelic Drug Stocks Index Up 18.5% In Past 2 Weeks

Biopharmaceutical companies doing research into psychedelic compounds for the treatment of mental health problems has almost doubled in the last 3 months to 38.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.